Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Haruhisa Inoue

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
BMJ Open|December 5, 2019
Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patientsKeiko Imamura, Yuishin Izumi, Haruhiko Banno, et al.
Nature Communications|July 12, 2018
A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse modelNaomi Tsuburaya, Kengo Homma, Tsunehiko Higuchi, et al.
Scientific Reports|October 17, 2022
Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naive stateHajime Ozaki, Hidetaka Suga, Mayu Sakakibara, et al.
Scientific Reports|April 7, 2019
Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cellsShin-Ichiro Sekine, Masayuki Kaneko, Masaki Tanaka, et al.
Clinical Science (London, England : 1979)|February 20, 2019
<i>MiR-33a</i> is a therapeutic target in SPG4-related hereditary spastic paraplegia human neuronsFumiko Nakazeki, Itaru Tsuge, Takahiro Horie, et al.
Life Science Alliance|June 16, 2021
DNA damage in embryonic neural stem cell determines FTLDs' fate via early-stage neuronal necrosisHidenori Homma, Hikari Tanaka, Meihua Jin, et al.
Cell Reports|March 12, 2014
A chemical probe that labels human pluripotent stem cellsNao Hirata, Masato Nakagawa, Yuto Fujibayashi, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 18, 2021
[Recommendations (Proposal) for promoting research for overcoming neurological diseases 2020]Hideki Mochizuki, Masashi Aoki, Kensuke Ikenaka, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 1, 2022
[Recommendations (Proposal) for promoting research for overcoming neurological diseases 2020]Hideki Mochizuki, Masashi Aoki, Kensuke Ikenaka, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 1, 2022
[Recommendations (Proposal) for promoting research for overcoming neurological diseases 2020]Hideki Mochizuki, Masashi Aoki, Kensuke Ikenaka, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
BMJ Open|December 5, 2019
Induced pluripotent stem cell-based Drug Repurposing for Amyotrophic lateral sclerosis Medicine (iDReAM) study: protocol for a phase I dose escalation study of bosutinib for amyotrophic lateral sclerosis patientsKeiko Imamura, Yuishin Izumi, Haruhiko Banno, et al.
Nature Communications|July 12, 2018
A small-molecule inhibitor of SOD1-Derlin-1 interaction ameliorates pathology in an ALS mouse modelNaomi Tsuburaya, Kengo Homma, Tsunehiko Higuchi, et al.
Scientific Reports|October 17, 2022
Differentiation of human induced pluripotent stem cells into hypothalamic vasopressin neurons with minimal exogenous signals and partial conversion to the naive stateHajime Ozaki, Hidetaka Suga, Mayu Sakakibara, et al.
Scientific Reports|April 7, 2019
Functional evaluation of PDGFB-variants in idiopathic basal ganglia calcification, using patient-derived iPS cellsShin-Ichiro Sekine, Masayuki Kaneko, Masaki Tanaka, et al.
Clinical Science (London, England : 1979)|February 20, 2019
<i>MiR-33a</i> is a therapeutic target in SPG4-related hereditary spastic paraplegia human neuronsFumiko Nakazeki, Itaru Tsuge, Takahiro Horie, et al.
Life Science Alliance|June 16, 2021
DNA damage in embryonic neural stem cell determines FTLDs' fate via early-stage neuronal necrosisHidenori Homma, Hikari Tanaka, Meihua Jin, et al.
Cell Reports|March 12, 2014
A chemical probe that labels human pluripotent stem cellsNao Hirata, Masato Nakagawa, Yuto Fujibayashi, et al.
Rinsho Shinkeigaku = Clinical Neurology|October 18, 2021
[Recommendations (Proposal) for promoting research for overcoming neurological diseases 2020]Hideki Mochizuki, Masashi Aoki, Kensuke Ikenaka, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 1, 2022
[Recommendations (Proposal) for promoting research for overcoming neurological diseases 2020]Hideki Mochizuki, Masashi Aoki, Kensuke Ikenaka, et al.
Rinsho Shinkeigaku = Clinical Neurology|June 1, 2022
[Recommendations (Proposal) for promoting research for overcoming neurological diseases 2020]Hideki Mochizuki, Masashi Aoki, Kensuke Ikenaka, et al.
Pageof 14